| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.3 |